Research Solutions, Inc

Standby, your program is about to begin. If you need assistance during your conference today, please press star zero. Good afternoon, everyone, and thank you for participating in today's conference call to discuss Research Solutions Financial and Operating Results for its fiscal 2026 first quarter ended September 30, 2025. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, John Beisler, Investor Relations.

Thank you, operator, and good afternoon, everyone. Thank you for joining us today for Research Solutions' first quarter fiscal year 2026 earnings call. On the call with me today are Roy W. Olivier, President and Chief Executive Officer, Bill Northern, Chief Financial Officer, and Josh Nicholson, Chief Strategy Officer. After the market closed this afternoon, the company issued a press release announcing its results for the first quarter of fiscal 2026. The release is available on the company's website, researchsolutions.com. Before Roy, Bill, and Josh begin their prepared remarks, I would like to remind you that some of the statements made today will be forward-looking and are made under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those expressed or implied due to a variety of factors. We refer you to Research Solutions' recent filings with the SEC for a more detailed discussion of the risks and uncertainties that could impact the company's future operating results and financial condition. Also on today's call, management will reference certain non-GAAP financial measures, which we believe provide useful information for investors. A reconciliation of those measures, the GAAP measures, is included in today's earnings press release as well. Finally, I would like to again remind everyone this call is being recorded and made available for replay via a link on the company's website. I would now like to turn the call over to President and CEO Roy W. Olivier. Roy?

Thank you, John. The first quarter continued our progress in improving our B2B new logo sales teams as well as our transformation to becoming a comprehensive SaaS and AI solution for scientific research. It is the strongest organic first quarter B2B results on record. Total ARR for the quarter is up 21% driven by that strong B2B performance. That performance includes closing some of the largest deals in the company's history, including new platform sales to Real Chemistry, a top 10 pharma company, and others. This resulted in the company's ASP increasing and also contributed to driving our second highest quarterly adjusted EBITDA result, as well as strong cash flow. I'd like to pass it over to Bill to walk you through the financial, I'm sorry, the fiscal first quarter financial results in detail, and then I'll wrap up with some comments and outlook for the remainder of the year. And Josh will discuss our strategy. Bill?